Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
The purpose of the study is to learn if a urine and sputum test can be used to measure if lung damage occurs over a long period of time (two years) or when patients are sick. Another purpose is to learn if treatment in the hospital with antibiotics and airway clearance decreases the amount of damage done to lungs. We would like to develop a urine and sputum test to help us to better understand what happens in patients lungs over time and when you get sick.
8 Years - 25 Years
>= 35 Percent Predicted
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
The Minnesota Cystic Fibrosis Center (Pediatric), Minneapolis, MN, 55455
Grover, Patricia Phone: (612) 626-7425 Email: Grove026@umn.edu